CorMedix Inc Forecast, price target & analysts
CorMedix Inc Target price 2025 - Analyst rating & recommendation
CorMedix Inc Classifications & Recommendation:
CorMedix Inc Price Target
| Target Price | $20.40 |
| Price | $11.42 |
| Potential |
78.63%
register free of charge
|
| Number of Estimates | 9 |
|
9 Analysts have issued a price target CorMedix Inc 2026 .
The average CorMedix Inc target price is $20.40.
This is
78.63%
register free of charge
$23.10
102.28%
register free of charge
$14.14
23.82%
register free of charge
|
|
| A rating was issued by 13 analysts: 12 Analysts recommend CorMedix Inc to buy, 1 to hold and 0 to sell. | |
| Analysts don't have a crystal ball either, but they do represent the opinion of the market quite well. You should not take the price potential and the ratings as a recommendation to act. Rather, they serve as an additional building block for your own opinion or stock analysis. | |
|
Analyst Estimates: Analysts believe that the CorMedix Inc stock has an average upside potential 2026 of
78.63%
register free of charge
|
Sales and Margin forecast 2025, 2026 to 2032
| Dec '24 |
2025 Estimates |
|
|---|---|---|
| Revenue Million $ | 43.47 | 289.37 |
| 565.68% | ||
| EBITDA Margin | -50.72% | 49.16% |
| 196.92% | ||
| Net Margin | -41.25% | 54.65% |
| 232.50% |
9 Analysts have issued a sales forecast CorMedix Inc 2025 . The average CorMedix Inc sales estimate is
This results in the following potential growth metrics:
3 Analysts have issued an CorMedix Inc EBITDA forecast 2025. The average CorMedix Inc EBITDA estimate is
This results in the following potential growth metrics and future EBITDA Margins:
9 CorMedix Inc Analysts have issued a net profit forecast 2025. The average CorMedix Inc net profit estimate is
This results in the following potential growth metrics and future Net Margins:
Earnings per share, P/E ratio and EV/sales Estimates 2025, 2026 to 2032
| Dec '24 |
2025 Estimates |
|
|---|---|---|
| Earnings Per Share $ | -0.30 | 2.12 |
| 67.03% | 806.67% | |
| P/E | 5.39 | |
| EV/Sales | 2.43 |
9 Analysts have issued a CorMedix Inc forecast for earnings per share. The average CorMedix Inc EPS is
This results in the following potential growth metrics and future valuations:
Current CorMedix Inc Upgrades & Downgrades
| Analyst | Rating | Action | Date |
|---|---|---|---|
| RBC Capital |
Locked
➜
Locked
|
Locked | Oct 21 2025 |
| D. Boral Capital |
Locked
➜
Locked
|
Locked | Oct 20 2025 |
| JMP Securities |
Locked
➜
Locked
|
Locked | Sep 09 2025 |
| HC Wainwright & Co. |
Locked
➜
Locked
|
Locked | Aug 08 2025 |
| HC Wainwright & Co. |
Locked
➜
Locked
|
Locked | Jun 30 2025 |
| D. Boral Capital |
Locked
➜
Locked
|
Locked | Jun 30 2025 |
| Needham |
Locked
➜
Locked
|
Locked | Jun 24 2025 |
| Analyst Rating | Date |
|---|---|
|
Locked
RBC Capital:
Locked
➜
Locked
|
Oct 21 2025 |
|
Locked
D. Boral Capital:
Locked
➜
Locked
|
Oct 20 2025 |
|
Locked
JMP Securities:
Locked
➜
Locked
|
Sep 09 2025 |
|
Locked
HC Wainwright & Co.:
Locked
➜
Locked
|
Aug 08 2025 |
|
Locked
HC Wainwright & Co.:
Locked
➜
Locked
|
Jun 30 2025 |
|
Locked
D. Boral Capital:
Locked
➜
Locked
|
Jun 30 2025 |
|
Locked
Needham:
Locked
➜
Locked
|
Jun 24 2025 |
Discover more stocks with a high price target
Register for Free
StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.
